Bio-Techne Corporation (TECH) Stock

Healthcare · Biotechnology · Member of S&P 500

Bio-Techne Corporation (TECH) closed at USD 72.50 on 2026-10-14, a change of +14 % over the past year, with a market capitalization of USD 11.37B.

Bio-Techne Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Bio-Techne Corporation key figures

Previous close

USD 72.50 (2026-10-14)

1-year change

+14 %

Market cap

USD 11.37B

Enterprise value

USD 11.4B

P/E ratio (trailing)

62.52

P/E ratio (forward)

31.36

EPS (trailing)

1.16

EPS (forward)

2.31

PEG ratio

2.11

Price to book

5.37

Revenue growth

1.3 %

Earnings growth

n/a

Dividend per share (trailing)

0.32

Short ratio

2.42

Employees

3,000

Analyst consensus (third-party)

hold

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. Its Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Bio-Techne Corporation and compare it with other stocks.